INOVIO PHARMACEUTICALS, INC. 8-K

What Happened

• On March 12, 2026, Inovio Pharmaceuticals, Inc. announced and furnished a press release reporting its financial results for the quarter and full year ended December 31, 2025. The announcement was made via Form 8‑K under Item 2.02 (Results of Operations and Financial Condition) and the press release is included as Exhibit 99.1.

Key Details

• Filing date: March 12, 2026
• Reporting period: Quarter and full year ended December 31, 2025
• Document furnished: Press release announcing financial results (Exhibit 99.1)
• Form 8-K item: Item 2.02 (Results of Operations and Financial Condition)

Why It Matters

• This 8‑K signals Inovio has publicly reported its quarterly and full‑year earnings and related financial information for 2025. Retail investors should review the furnished press release (Exhibit 99.1) for specific figures on revenue, net income or loss, cash position, and any operational updates, and consult the company’s upcoming SEC periodic filings for full audited details and disclosures.